The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.
 
Laia Garrigos
No Relationships to Disclose
 
Ana Santaballa
No Relationships to Disclose
 
Alicia Hurtado
No Relationships to Disclose
 
Juan Francisco Rodriguez-Moreno
No Relationships to Disclose
 
Ricardo Sanchez-escribano
No Relationships to Disclose
 
Andres Redondo
No Relationships to Disclose
 
Nuria Lainez
No Relationships to Disclose
 
M Jesus Rubio
No Relationships to Disclose
 
Isabel Bover
No Relationships to Disclose
 
Juan Fernando Cueva
No Relationships to Disclose
 
Susana Hernando Polo
No Relationships to Disclose
 
Marta Izquierdo Manuel
No Relationships to Disclose
 
Mario Prieto
No Relationships to Disclose
 
Jose Antonio Lopez-Guerrero
No Relationships to Disclose
 
Zaida Garcia-Casado
No Relationships to Disclose
 
Ignacio Perez
No Relationships to Disclose
 
Ramon De Las Penas
No Relationships to Disclose
 
Enrique Grande
No Relationships to Disclose
 
Jesús García-Donas
No Relationships to Disclose